LEADER 02443oam  2200697   450 
001 9910715330703321
005 20220609074945.0
024 8 $a43-010
035   $a(CKB)5470000002510729
035   $a(OCoLC)1240365378
035   $a(EXLCZ)995470000002510729
100   $a20210303d2021      ua             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 14$aThe role of Purdue Pharma and the Sackler family in the opioid epidemic $ehearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, second session, December 17, 2020
210  1$aWashington :$cU.S. Government Publishing Office,$d2021.
215   $a1 online resource (iii, 62 pages) +$e2 errata (1 page)
300   $aAccess ID (govinfo): CHRG-116hhrg43010.
300   $a"Serial no. 116-130."
300   $aErrata corrects transcription errors on pages 14 and 27.
300   $aErrata II corrects transcription errors on page 27.
320   $aIncludes bibliographical references.
517   $aRole of Purdue Pharma and the Sackler family in the opioid epidemic 
606   $aOpioid abuse$zUnited States
606   $aPharmaceutical industry$xCorrupt practices$zUnited States
606   $aDrugs$zUnited States$xMarketing
606   $aOxycodone abuse$zUnited States
606   $aCorruption$2fast
606   $aDrugs$xMarketing$2fast
606   $aOpioid abuse$2fast
606   $aOxycodone abuse$2fast
606   $aPharmaceutical industry$xCorrupt practices$2fast
607   $aUnited States$2fast
608   $aLegislative hearings.$2fast
608   $aLegislative hearings.$2lcgft
615  0$aOpioid abuse
615  0$aPharmaceutical industry$xCorrupt practices
615  0$aDrugs$xMarketing.
615  0$aOxycodone abuse
615  7$aCorruption.
615  7$aDrugs$xMarketing.
615  7$aOpioid abuse.
615  7$aOxycodone abuse.
615  7$aPharmaceutical industry$xCorrupt practices.
676   $a4.OV 2:116-130
801  0$bGPO
801  1$bGPO
801  2$bGPO
801  2$bOCLCO
801  2$bDWP
801  2$bOCLCF
801  2$bGPO
801  2$bOCLCQ
801  2$bGPO
906   $aBOOK
912   $a9910715330703321
996   $aThe role of Purdue Pharma and the Sackler family in the opioid epidemic$93549524
997   $aUNINA